Easing the Disease Burden of Patients with Atopic Dermatitis artwork

Easing the Disease Burden of Patients with Atopic Dermatitis

5 episodes - English - Latest episode: over 2 years ago -

Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to

Medicine Health & Fitness
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

Emerging Therapies: Phase 3 Efficacy & Safety Data

November 01, 2021 15:16 - 16 minutes - 15.3 MB

JAK-STAT inhibitors: oral and topical JAK-STAT inhibitors vs dupilumab IL-13 antagonists IL-31 antagonists

AD Therapies Approved After 2014 AAD Guidelines

November 01, 2021 15:16 - 12 minutes - 11.1 MB

Mechanism of action, indication, efficacy, and safety Dupilumab Crisaborole

Adherence to Evidence-Based Guidelines

November 01, 2021 15:15 - 6 minutes - 5.6 MB

2014 AAD Guidelines Recommendations for topical therapies Recommendations for phototherapy

Components of Basic AD Care

November 01, 2021 15:15 - 4 minutes - 4.08 MB

Role of bathing and moisturizers Role of topical corticosteroids

Unmet Needs in AD Care

November 01, 2021 15:15 - 4 minutes - 4.44 MB

Direct and indirect effects of AD Discordance in disease burden between providers and patients Rates of inadequate disease control